Self-reported feelings of anger and aggression towards others in patients on levetiracetam: Data from the UK antiepileptic drug register

BMJ Open

Volumn 3, Issue 3, 2013, Pages

  Wieshmann, Udo Carl ^a   Baker, Gus A ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ESCITALOPRAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LORAZEPAM; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PREGABALIN; PRIMIDONE; RUFINAMIDE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; AGGRESSION; ANGER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE CONTROL; EPILEPSY; FEMALE; FOUR POINT LIKERT SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POLYPHARMACY; RATING SCALE; SELF REPORT; SIDE EFFECT; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84876116287     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002564     Document Type: Article

References (13)

1. Abou-Khalil B. Benefit: risk assessment of levetiracetam in the treatment of partial seizures. Drug Saf 2005;28:871-90. (Pubitemid 41428544)
2. Cramer JA, De Rue K, Devinsky O, et al. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav 2003;4:124-32. (Pubitemid 37184583)
3. Mula M, Trimble MR, Yuen R, et al. Psychiatric adverse events during levetiracetam therapy. Neurology 2003;61:704-6. (Pubitemid 37082613)
4. White JR, Walczak TS, Leppik J, et al. Discontinuation of levetiracetam because of behavioral side effects: a case control study. Neurology 2003;61:1218-21. (Pubitemid 37377540)
5. Barrow P, Waller P, Wise L. Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions. Br J Clin Pharmacol 2005;61:233-7. (Pubitemid 43382618)
6. Gilliam FG, Fessler AJ, Baker G, et al. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62:23-7. (Pubitemid 38082864)
7. French J, Edrich P, Cramer JA. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res 2001;47:77-90. (Pubitemid 32973650)
8. Helmstaedter C, Fritz NE, Kockelmann E, et al. Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav 2008;13:535-41.
9. Wieshmann UC, Tan GM, Baker G. Self-reported symptoms in patients on antiepileptic drugs in monotherapy. Acta Neurol Scand 2011;124:355-8
10. Labiner DM, Ettinger AB, Fakhoury TA, et al. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia 2009;50:434-42.
11. Shorvon SD, Van Rijckevorsel K. A new antiepileptic drug. J Neurol Neurosurg Psychiatry 2002;72:426-8.
12. Nicolson A, Lewis SA, Smith DF. A prospective analysis of the outcome of levetiracetam in clinical practice. Neurology 2004;63:568-70. (Pubitemid 39031397)
13. Hunt S, Craig J, Russell A, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006;67:1876-9. (Pubitemid 44900776)